CASE COMMENTS: EUROPEAN AND INTERNATIONAL LAW – USA – PUBLIC ENFORCEMENT – CARTEL – PAY-FOR-DELAY

United States: The Federal Trade Commission rules that two pharmaceutical laboratories concluded an unlawful pay-for-delay agreement (Endo / Impax)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. No loosening of deferral of entry agreements appears to be the direction given to FTC officers. In its Opinion written by Noah Joshua Phillips, the U.S. Competition Authority

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • University of Grenoble Alpes

Quotation

Walid Chaiehloudj, United States: The Federal Trade Commission rules that two pharmaceutical laboratories concluded an unlawful pay-for-delay agreement (Endo / Impax), 28 March 2019, Concurrences N° 2-2019, Art. N° 90539, pp. 208

Visites 223

All reviews